Our study focused on studying the effect of transferrin-conjugated gold nanoparticles (Au-Tf) on the antioxidant pathway protein expression, with a specific focus on the glutathione-thioredoxin pathway, cell morphology, and cell cycle of PC-3 metastatic prostate cancer cells for both acute and chronic exposure conditions. The gene discussed is TXN; the disease is prostate cancer.